CD274 and cancer: To select mouse cancer cells before proceeding with the in vivo experiment, we studied the expression of PD-L1 and HMGCR, the target receptors of ATO, in several mouse cancer cell lines, including breast (4T1, EMT6), colorectal (CT26), and lung (LLC1) cancer cells.